Publicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (6)

2019

  1. A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments

    Translational Psychiatry, Vol. 9, Núm. 1

2014

  1. Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain

    Schizophrenia Research, Vol. 159, Núm. 1, pp. 107-113

2012

  1. Protocolo breve de evaluación del suicidio: Fiabilidad interexaminadores

    Revista de Psiquiatria y Salud Mental, Vol. 5, Núm. 1, pp. 24-36

2007

  1. Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia outpatients with prominent negative symptoms

    European Neuropsychopharmacology, Vol. 17, Núm. 11, pp. 725-734

1998

  1. Pharmacoeconomic assessment of olanzapine in the treatment of refractory schizophrenia based on a pilot clinical study

    Clinical Drug Investigation, Vol. 15, Núm. 1, pp. 29-35

1997

  1. Olanzapine in treatment-refractory schizophrenia: Results of an open- label study

    Journal of Clinical Psychiatry, Vol. 58, Núm. 11, pp. 479-483